Saturday, July 27, 2019 10:17:32 AM
Wow. Your messages have caused a response on the other board.I followed messages on the turv board as best I could and and they lead me to these on the exdi board not the ihub.
iphawk
Why would anyone buy the common stock when they are constantly raising money at half the current stock price?
TIA!
ldm
Why ask about that? Read the SEC filings.
"As disclosed in our Current Reports on Form 8-K filed February 21, 2019, February 28, 2019, March 6, 2019, and March 14, 2019 we have previously accepted subscriptions of $3,023,253 for a total of 14,471,474 shares of Common Stock. On March 29, 2019 we accepted additional subscriptions in the total amount $327,016 for an additional 1,113,642 shares of Common Stock. The offer and sale of these shares was made solely to "Accredited Investors" as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933 (the “Securities Act”). We engaged in no general solicitation or advertising with regard to the offering. Accordingly, the offer and sale of these shares was exempt under Rule 506 of Regulation D under the Securities Act.
Following the issuance of common stock as described above, our total issued and outstanding common stock will be 32,641,884 shares."
A little use of the calculator will show that there were 15,585,116 shares placed for a total of $3,350,269. That averages $0.2149 price per share. On Feb 28, when this nonsense started the share price was $0.80.
Also, read the company history in the 10Q. It is a screwball history like TURV with multiple business pivots and no profits.
Recent PLSH News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 12:37:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 05:40:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 01:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 03:28:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 07:24:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/08/2023 08:04:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 05:07:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:15:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 04:21:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 03:28:18 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 03:19:11 PM
- Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast • InvestorsHub NewsWire • 07/18/2023 04:41:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 01:00:13 PM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM